Home › Core › ISCC-IDs › 28CrWgbM3wrVR

View ISCC-ID

Core Data

28CrWgbM3wrVR
ISCC-ID - digital asset identifier
CCD7iPo5taEpi-CTLNQd9jmqYpK-CDEJ2RQah8zQD-CRhiCnNvp3rw9
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

phase i trial of rituximab cladribine and temsirolimus rct for initial therapy of mantle cell lymphoma

Ledger Reference

coblo
Source Ledger/Blockchain
458267
N-th ISCC Decleration on source ledger
563d55e061d7359363afc5f9dcbdbf57325b1deda25c21db4c50ced1ef887b9f
Hash of block that includes the ISCC-DECLARATION
9da236d3693dfcb25fe2b895e340f9fc604d015b93a7c0a2f658faa2651fce84
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "D. J. Inwards", "@type": "Person"}, {"name": "P. A. Fishkin", "@type": "Person"}, {"name": "B. R. LaPlant", "@type": "Person"}, {"name": "M. T. Drake", "@type": "Person"}, {"name": "P. J. Kurtin", "@type": "Person"}, {"name": "D. A. Nikcevich", "@type": "Person"}, {"name": "D. B. Wender", "@type": "Person"}, {"name": "B. S. Lair", "@type": "Person"}, {"name": "T. E. Witzig", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc5808677?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Oxford University Press (OUP)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1093/annonc/mdu273", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCD7iPo5taEpi-CTLNQd9jmqYpK-CDEJ2RQah8zQD-CRhiCnNvp3rw9", "propertyID": "ISCC"}], "datePublished": "2014-07-23"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close